Harbor Capital Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,302
Closed -$6.72K 665
2023
Q2
$6.72K Buy
+2,302
New +$5.21K ﹤0.01% 652

Other funds holding RNLX

Harbor Capital Advisors's RNLX Position: Q3 2023 in Review

Harbor Capital Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2023, closing a stake of 2,302 shares — an estimated $6.72K sold.

Harbor Capital Advisors first reported a position in RNLX in Q2 2023 and held it in 1 quarter. The position peaked at $6.72K in Q2 2023. 26 funds tracked by Wall St. Rank hold RNLX as of Q3 2023.

  • Harbor Capital Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Harbor Capital Advisors sold 2,302 Renalytix plc American Depositary Shares shares in Q3 2023, an estimated $6.72K.
  • Harbor Capital Advisors first reported a position in Renalytix plc American Depositary Shares in Q2 2023 and held it in 1 quarter.
  • Harbor Capital Advisors's Renalytix plc American Depositary Shares position peaked at $6.72K in Q2 2023.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2023.

Based on Harbor Capital Advisors's 13F filing for Q3 2023, filed 20 Oct 2023.